Skip to main content
TGTX logo

TGTX · Tg Therapeutics, Inc. · Debt

Track TGTX — free
Market Cap
$8.25B
Shares
153.07M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1001316 CUSIP 88322Q108 13F (30d) 101 filings 100 filers Visit website Investor relations